Sales & Marketing News | pharmaphorum

News

BIOSECURE Act clears House vote

The US House of Representatives comprehensively voted in favour of the BIOSECURE Act, which will prohibit businesses in the US from contracting with various Chinese firms on national securi

News

NICE clears NHS use of MSD's Welireg for genetic disorder

Patients in England and Wales with a rare genetic disorder will soon be able to access treatment with MSD's Welireg via the NHS, nearly a year after their counterparts in Scotland.

News

Lykos CEO steps down after MDMA is rejected by FDA

The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down.

News

AstraZeneca China HQ: at Shanghai Zhangjiang Hi-Tech Park

China detains AstraZeneca workers in data, imports probe

AstraZeneca has confirmed that some of its current and former employees have been taken into custody in China as part of an investigation into data privacy breaches and the import of unlice

News

J&J sweetens controversial talc settlement deal

In a bid to put litigation over the safety of its talc products into the rearview mirror, Johnson & Johnson has added another $1.1 billion to its settlement offer, according to media re

News

Advanz wins stay on EU revocation of Ocaliva license

There's been another twist to the tale of Advanz Pharma's efforts to keep its primary biliary cholangitis (PBC) therapy Ocaliva on the market in the EU.

BIOSECURE Act clears House vote

NICE clears NHS use of MSD's Welireg for genetic disorder

Lykos CEO steps down after MDMA is rejected by FDA

China detains AstraZeneca workers in data, imports probe

J&J sweetens controversial talc settlement deal

Advanz wins stay on EU revocation of Ocaliva license

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks